Background: Disseminated aspergillosis (DA) in dogs has a guarded prognosis and there is a lack of a gold standard treatment protocol.
Objective: To retrospectively assess survival times and factors influencing survival times.
Animals: Dogs diagnosed with DA from January 2007 to June 2017.
Objective: The goal of this pilot study was to compare regular insulin administered by continuous rate infusion (CRI) to an approach using insulin glargine and regular insulin administered intermittently.
Design: Prospective randomized clinical trial.
Setting: University teaching hospital.